Search results
BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial
Benzinga via Yahoo Finance· 2 years agoBridgeBio Pharma Inc (NASDAQ: BBIO) has dosed the first patient in its Phase 1 trial of BBP-671, an...
BridgeBio Pharma Posts Early Data From Neurological Movement Disorder Candidate
Benzinga via Yahoo Finance· 2 years agoBridgeBio Pharma Inc (NASDAQ: BBIO) has announced interim Phase 1 data from healthy volunteers,...
Calculating The Fair Value Of Hor Kew Corporation Limited (SGX:BBP)
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Hor Kew fair value estimate is S$0.25 Hor...
Baton Rouge Automation Manufacturer to Expand Headquarters
IEN via Yahoo Finance· 1 month agoBBP, a Louisiana-based automation solutions manufacturing company, announced it is expanding its...
Hor Kew Corporation Limited's (SGX:BBP) Price Is Right But Growth Is Lacking
Simply Wall St. via Yahoo Finance· 2 years agoWhen close to half the companies in Singapore have price-to-earnings ratios (or "P/E's") above 11x,...
Louisiana manufacturing company expands Baton Rouge headquarters in $4.2 million project
WVLA Baton Rouge via Yahoo Finance· 1 month agoA Louisiana-based automation solutions manufacturing company called BBP is investing $4.2 million...
The Zacks Analyst Blog Highlights BBC, CNCR XBI, BBP, and SBIO
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 11, 2022 – Zacks.com announces the list of stocks featured...
Hor Kew (SGX:BBP) Is Doing The Right Things To Multiply Its Share Price
Simply Wall St. via Yahoo Finance· 6 months agoIf we want to find a stock that could multiply over the long term, what are the underlying trends we...
Hor Kew (SGX:BBP) Is Looking To Continue Growing Its Returns On Capital
Simply Wall St. via Yahoo Finance· 2 weeks agoWhat trends should we look for it we want to identify stocks that can multiply in value over the...
BridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor
Zacks via Yahoo Finance· 2 years agoShares of BridgeBio Pharma, Inc. BBIO were up 14% on Thursday May 12, after management announced...